Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-02

Clinical Trial Update: The Treatment of Lenalidomide in Patients With POEMS Syndrome [Phase 2]

View source ↗

Summary

This entry concerns a Phase 2 clinical trial evaluating lenalidomide for POEMS syndrome. The status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Revlimid (lenalidomide)

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: POEMS Syndrome | Phase 2 | Status: UNKNOWN